Mark C. Blunt
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Nosocomial Infections in ICU
Papers in
-
- Airway Management and Intubation Techniques 5
- Anesthesia and Sedative Agents 4
-
- COVID-19 Clinical Research Studies 8
- Infection Control in Healthcare 3
- Co-authors
- Peter Young (12 shared papers)Kenneth R Burchett (1 shared paper)Rupert M. Pearse (1 shared paper)Rachael A. Scott (1 shared paper)Neil MacDonald (1 shared paper)Michael Gillies (1 shared paper)Michael P. W. Grocott (1 shared paper)Charles Hinds (1 shared paper)
- Journals
- The Lancet (8 papers)Nature (4 papers)JAMA (3 papers)Anesthesiology (2 papers)American Journal of Infection Control (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Mark C. Blunt
34 papers receiving 3.9k citations
Mark C. Blunt's Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 1.8k
- Critical Care and Intensive Care Medicine 153
- Anesthesiology and Pain Medicine 164
- Genetics 514
- Emergency Medical Services 103
Countries citing papers authored by Mark C. Blunt
This map shows the geographic impact of Mark C. Blunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Blunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Blunt more than expected).
Fields of papers citing papers by Mark C. Blunt
This network shows the impact of papers produced by Mark C. Blunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Blunt. The network helps show where Mark C. Blunt may publish in the future.
Co-authors
The 18 scholars most cited alongside Mark C. Blunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Effect of a Perioperative, Cardiac Output–Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery Hit paper breakdown → | 2014 | 651 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | 2021 | 213 | |
| 9 | 2019 | 137 | |
| 10 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 11 | 2000 | 120 | |
| 12 | 2017 | 112 | |
| 13 | 2006 | 106 | |
| 14 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 15 | 2001 | 71 | |
| 16 | 2023 | 60 | |
| 17 | 2021 | 43 | |
| 18 | 2016 | 41 | |
| 19 | 2019 | 20 | |
| 20 | 2013 | 18 |
About Mark C. Blunt
Mark C. Blunt is a scholar working on Anesthesiology and Pain Medicine, Infectious Diseases, Emergency Medical Services, Critical Care and Intensive Care Medicine and Genetics, having authored 38 papers that have together received 4.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Patient Safety and Medication Errors (5 papers), Airway Management and Intubation Techniques (5 papers), Genetic Associations and Epidemiology (5 papers), Anesthesia and Sedative Agents (4 papers), Infection Control in Healthcare (3 papers), Respiratory Support and Mechanisms (3 papers) and Central Venous Catheters and Hemodialysis (2 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Critical Care and Intensive Care Medicine (153 citations), Anesthesiology and Pain Medicine (164 citations), Genetics (514 citations) and Emergency Medical Services (103 citations). Mark C. Blunt has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Peter Young, Kenneth R Burchett, Rupert M. Pearse, Rachael A. Scott, Neil MacDonald, Michael Gillies, Michael P. W. Grocott, Charles Hinds, Kathy Rowan and Gareth L. Ackland. Their work appears in journals such as The Lancet, Nature, JAMA, Anesthesiology and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.